Ultragenyx Rare Day
A Hutt making an appearance at Rare Day #ultragenyx #rareday
@tygreyes.bsky.social
@tygreyes.bsky.socialUltragenyx Rare Day
A Hutt making an appearance at Rare Day #ultragenyx #rareday
@newsen.bsky.socialPomerantz Law Firm Launches Investigation into Ultragenyx Pharmaceutical Inc. Investors' Claims #United_States #New_York #Securities_Fraud #Pomerantz_LLP #Ultragenyx
@thedailyfathom.bsky.socialBIOTECH · Ultragenyx's Angelman syndrome drug fails Phase 3 trial
Ultragenyx's experimental drug for the rare disorder Angelman syndrome missed its main goals in a major trial, and shares dropped over 40%.